← Open Payments lookup

KRISTEN GRABLE: Open Payments

NPI 1720001118 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$837 in 45 payments from 10 companies in 2025. Trend: 2023 $546 · 2024 $457 · 2025 $837

Food & beverage: $837
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.19$297
Neurocrine BioSciences, Inc.9$209
Teva Pharmaceuticals USA, Inc.4$90
Otsuka America Pharmaceutical, Inc.4$72
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$49
Alkermes, Inc.2$37
ABBVIE INC.1$28
Axsome Therapeutics, Inc.1$22
Supernus Pharmaceuticals, Inc.1$18
Janssen Pharmaceuticals, Inc1$14

Products named: COBENFY, INGREZZA, UZEDY, ABILIFY ASIMTUFII, CAPLYTA, VRAYLAR, LYBALVI, Auvelity.

Industry payments across TX — which companies pay providers there.